Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment
https://doi.org/10.14412/1996-7012-2019-2-9-21
Abstract
For the first time, the paper presents in detail the prevalence of osteoarthritis (OA) and considers the predictors of disease development and progression. The clinical classification of OA and its place in the ICD-10 are described. The clinical presentation of the disease is characterized in detail according to the localization of the process. It is noted that there is a change in the understanding of OA as a classic model of nociceptive pain. The paper depicts clinical, laboratory, and instrumental methods for diagnosing the disease, as well as classification and diagnostic criteria; much attention is paid to the current principles of OA therapy according to the Russian clinical recommendations and the guidelines of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the European League Against Rheumatism (EULAR).
About the Authors
L. I. Alekseeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoye Shosse, Moscow 115522
Russian Federation
34A, Kashirskoye Shosse, Moscow 115522
E. A. Taskina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoye Shosse, Moscow 115522
Russian Federation
34A, Kashirskoye Shosse, Moscow 115522
N. G. Kashevarova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoye Shosse, Moscow 115522
Russian Federation
34A, Kashirskoye Shosse, Moscow 115522
References
1. Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health. 1984 Jun; 74(6):574-9. 2. Branco JC, Rodrigues AM, Gouveia N, et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on healthrelated quality of life, physical function and mental health in Portugal: results from EpiReumaPt – a national health survey. RMD Open. 2016 Jan 19;2(1):e000166. doi: 10.1136/rmdopen-2015-000166.
2. Grotle M, Hagen KB, Natvig B, et al. Рrevalence and burden of osteoarthritis: results from a population survey in Norway. J Rheumatol. 2008 Apr;35(4):677-84. Epub 2008 Feb 15.
3. Wallace IJ, Worthington S, Felson DT, et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017 Aug 29;114(35): 9332-9336. doi: 10.1073/pnas.1703856114. Epub 2017 Aug 14.
4. Balabanova RM, Erdes ShF. Trends in the prevalence of rheumatic diseases in ICD-10 in the adult population of the Russian Federation over 2000-2010. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;50(3): 10-2. (In Russ.). doi: 10.14412/1995-4484- 2012-702
5. Galushko EA, Bol'shakova TV, Vinogradova IB, et al. Structure of rheumatic diseases among adult population of Russia according to data of an epidemiological study (preliminary results). Nauchnoprakticheskaya revmatologiya = Rheumatology Science and Practice. 2009;47(1):11–7. (In Russ.). doi: 10.14412/1995-4484-2009-136
6. Comas M, Sala M, Romаn R, et al. Impact of the distinct diagnostic criteria used in population-based studies on estimation of the prevalence of knee osteoarthritis. Gac Sanit. 2010 Jan-Feb;24(1):28-32. doi: 10.1016/j.gaceta. 2009.06.002. Epub 2009 Sep 11.
7. Kim C, Linsenmeyer KD, Vlad SC, et al. Prevalence of radiographic and symptomatic hip osteoarthritis in an urban United States community: the Framingham osteoarthritis study. Arthritis Rheumatol. 2014 Nov; 66(11): 3013-7. doi: 10.1002/art.38795.
8. Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, et al. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among elderly: the Framingham Study. Am J Epidemiol. 2002 Dec 1;156(11):1021-7.
9. Bijlsma J, Berenbaum F, Lafeber P. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783): 2115-26. doi:10.1016/S0140-6736(11)60243-2.
10. Kashevarova NG, Alekseeva LI, Anikin SG, et al. Osteoarthritis of the knee: risk factors for the progression of joint disease in a five-year prospective disease. Proceedings of the III Eurasian Congress of rheumatologists, (Minsk, Republic of Belarus, 26-27 may 2016). Voprosy organizatsii i informatizatsii zdravookhraneniya. 2016;Suppl:144-9. (InRuss.).
11. Alekseeva LI, Anikin SG, Kashevarova NG, et al. Risk factors predicting radiological progression of knee osteoarthrosis. Ann Rheum Dis. 2018;77(Suppl):A797. doi: 10.1136/annrheumdis-2018-eular.2089
12. French HP, Smart KM, Doyle F. Prevalence of neuropathic pain in knee or hip osteoarthritis: a systematic review and metaanalysis. Semin Arthritis Rheum. 2017 Aug; 47(1):1-8. doi: 10.1016/j.semarthrit.2017. 02.008.
13. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957 Dec;16(4):494-502.
14. Smirnov AV. X-ray diagnosis of changes in the hip joint in rheumatic diseases. Consilium Medicum. 2003;5(8):442-6. (In Russ.).
15. Charles HC, Kraus VB, Ainslie M, Hellio Le Graverand-Gastineau MP. Editorial Optimization of the fixed-flexion knee radiograph. Osteoarthritis Cartilage. 2007 Nov;15(11):1221-4. Epub 2007 Oct 31.
16. Smirnov AV. Atlas rentgenologicheskoi diagnostiki pervichnogo osteoartroza [Atlas of x-ray diagnosis of primary osteoarthritis]. Moscow: IMA-PRESS; 2010. 21 p..
17. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986 Aug;29(8):1039-49.
18. Murav'ev YuV. Diagnostic and classification criteria in rheumatology: when should the criteria be used and how do they differ? Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2017;55(1):8-11. (In Russ.). doi: 10.14412/1995-4484-2017-8-11
19. Zhang W, Doherty M, Peat G, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010 Mar;69(3):483-9. doi: 10.1136/ard.2009.113100.
20. Altman R, Alarcn G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990 Nov;33(11):1601-10.
21. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis. 2009 Jan;68(1):8-17. doi: 10.1136/ard.2007. 084772. Epub 2008 Feb 4.
22. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991 May;34(5):505-14.
23. Alekseeva LI, Anikin SG, Sharapova EP, et al. Study of the efficacy, tolerance and safety of Chondrogard in patients with osteoarthritis. Russkii meditsinskii zhurnal. 2013;(32):1624-7. (In Russ.).
24. Sharapova EP, Alekseeva LI, Kashevarova NG, et al. Evaluation of efficacy, tolerability and chondrogard safety in patients with osteoarthritis of the knee and comorbidity. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2017;55(1S):138. (In Russ.).
25. Alekseeva LI, Sharapova EP, Kashevarova NG, et al. Comparative study of the efficacy and safety of Chondroguard® during its combined (intra-articular and intramuscular) and intramuscular injection in patients with knee osteoarthritis. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2018;12(2): 44–49. (In Russ.). doi: 10.14412/1996-7012-2018-2-44-49
26. Karateev AE, Nasonov EL, Ivashkin VT, et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2018;56(S1):1-29. (In Russ.). doi: doi.org/10.14412/rjtao20180
27. Derry S, Conaghan P, Da Silva J, et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016 Apr 22;4:CD007400. doi: 10.1002/ 14651858.CD007400.pub3.
28. Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults – an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017 May 12;5:CD008609. doi: 10.1002/14651858. CD008609.pub2.
29. Jü ni P, Hari R, Rutjes AW, et al. Intraarticular corticosteroid for knee osteoarthritis. Cochrane Database Syst Rev. 2015 Oct 22;(10): CD005328. doi: 10.1002/14651858. CD005328.pub3.
30. He WW, Kuang MJ, Zhao J, et al. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis. Int J Surg. 2017 Mar; 39:95-103. doi: 10.1016/j.ijsu.2017.01.087.
31. De Girolamo L, Kon E, Filardo G, et al. Regenerative approaches for the treatment of early OA. Knee Surg Sports Traumatol Arthrosc. 2016 Jun;24(6):1826-35. doi: 10.1007/s00167-016-4125-y. Epub 2016 Apr 27.
32. Filardo G, Kon E, Longo UG, et al. Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2016 Jun;24(6):1775-85. doi: 10.1007/s00167-016-4089-y. Epub 2016 Apr 4.
33. Uchio Y, Enomoto H, Alev L, et al. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patientswith knee pain due to osteoarthritis. J Pain Res. 2018 Apr 18;11: 809-821. doi: 10.2147/JPR.S164128. eCollection 2018.
34. Filatova ES, Turovskaya EF, Alekseeva LI. Complex therapy of chronic pain syndrome in patients with knee osteoarthritis. Effektivnaya farmakoterapiya. 2018;(19): 18-25. (In Russ.].
Review
For citations:
Alekseeva LI, Taskina EA, Kashevarova NG. Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2019;13(2):9-21. (In Russ.) https://doi.org/10.14412/1996-7012-2019-2-9-21
Views:
6126
Email this article 